Celon Pharma S.A. (GPW: CLN) Stock Analysis & Fundamentals | ScreenerHero

Create free account

CLNCelon Pharma S.A.

GPW · PL · Healthcare · Drug Manufacturers - Specialty & Generic · celonpharma.com

21.00PLN+7.14%Mkt Cap: 206.95M $P/E: 10.291d ago

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, …

Industry Peers

Drug Manufacturers - Specialty & Generic

$65.19BUSDP/E 23.7

United Therapeutics Corporation

$22.46BUSDP/E 19.5

Neurocrine Biosciences, Inc.

$17.25BUSDP/E 26.4

Swedish Orphan Biovitrum AB (publ)

$15.47BUSDP/E 179.2

$14.18BUSDP/E 29.7

Elanco Animal Health Incorporated

$8.93BUSDP/E 22.7

Hims & Hers Health, Inc.

Lantheus Holdings, Inc.

$6.84BUSDP/E 25.1

Liquidia Corporation

$6.69BUSDP/E 442.8

Amneal Pharmaceuticals, Inc.

$5.76BUSDP/E 48.8

Siegfried Holding AG

$3.65BUSDP/E 19.0

Hikma Pharmaceuticals PLC

$3.55BUSDP/E 11.3

Laboratorios Farmaceuticos Rovi, S.A.

$2.99BUSDP/E 20.9

Supernus Pharmaceuticals, Inc.

$2.52BUSDP/E 56.0

Dermapharm Holding SE

$2.35BUSDP/E 16.3

Prestige Consumer Healthcare Inc.

$2.40BUSDP/E 12.9

BioCryst Pharmaceuticals, Inc.

$1.92BUSDP/E 19.4

Amylyx Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

$1.86BUSDP/E 21.0

PolyPeptide Group AG

Bausch Health Companies Inc.

Faes Farma, S.A.

$1.48BUSDP/E 17.5

Xeris Biopharma Holdings, Inc.

$1.50BUSDP/E 124.1

Phibro Animal Health Corporation

$1.40BUSDP/E 14.8

BioGaia AB (publ)

$1.12BUSDP/E 35.4

Collegium Pharmaceutical, Inc.

$1.18BUSDP/E 17.6

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

Cronos Group Inc.

$1.06BUSDP/E Infinity

Eton Pharmaceuticals, Inc.

Pacira BioSciences, Inc.

$1.01BUSDP/E 196.9

BioAge Labs, Inc.

$918.60MUSDP/E 14.7

Pharmanutra S.p.A.

$873.22MUSDP/E 38.1

Amphastar Pharmaceuticals, Inc.

$875.69MUSDP/E 12.0

Esperion Therapeutics, Inc.

$819.46MUSDP/E Infinity

Knight Therapeutics Inc.

$692.84MUSDP/E 161.5

Ironwood Pharmaceuticals, Inc.

$637.05MUSDP/E 6.2

$505.77MUSDP/E 14.3

Aquestive Therapeutics, Inc.

Allergy Therapeutics plc

Canopy Growth Corporation

Emergent BioSolutions Inc.

Akebia Therapeutics, Inc.

Organogenesis Holdings Inc.

Deva Holding A.S.

Antibiotice S.A.

$320.48MUSDP/E 43.7

$294.94MUSDP/E 15.2

Cipher Pharmaceuticals Inc.

$303.08MUSDP/E 9.7

$273.62MUSDP/E 49.1

Alpha Teknova, Inc.

Animalcare Group plc

$250.29MUSDP/E 47.6

SIGA Technologies, Inc.

$255.34MUSDP/E 12.7

Laboratorio Reig Jofre, S.A.

$236.39MUSDP/E 53.0

Anika Therapeutics, Inc.

Journey Medical Corporation

Lifecore Biomedical, Inc.

Auxly Cannabis Group Inc.

$182.70MUSDP/E 8.8

Aurora Cannabis Inc.

$143.26MUSDP/E 18.3

Cardiol Therapeutics Inc.

Organigram Global Inc.

$119.66MUSDP/E 18.6

Cumberland Pharmaceuticals Inc.

Vistin Pharma ASA

$83.73MUSDP/E 12.0

HLS Therapeutics Inc.

Shield Therapeutics plc

Nanexa AB (publ)

$62.42MUSDP/E 52.6

ECO Animal Health Group plc

$63.44MUSDP/E 21.8

Orexo AB (publ)

Citius Oncology, Inc.

Cinclus Pharma Holding AB (publ)

Enzymatica AB (publ)

AB Science S.A.

Decibel Cannabis Company Inc.

Moberg Pharma AB (publ)

Turk Ilac Ve Serum Sanayi Anonim Sirketi

Malin Corporation plc

$33.86MUSDP/E Infinity

MediPharm Labs Corp.

BioXcel Therapeutics, Inc.

TherapeuticsMD, Inc.

$23.61MUSDP/E 204.0

Aytu BioPharma, Inc.

Rockwell Medical, Inc.

Rubicon Organics Inc.

Klaria Pharma Holding AB (publ.)

Voyageur Pharmaceuticals Ltd.

Medicon Hellas S.A.

$13.84MUSDP/E 16.8

Biofrontera Inc.

Caring Brands, Inc.

Apimeds Pharmaceuticals US, Inc.

PharmaCielo Ltd.

NUTEX Investments Public Limited Company

$6.05MUSDP/E 3.7

$6.48MUSDP/E 0.3

Sonoma Pharmaceuticals, Inc.

Mercanto Holdings Inc.

$5.46MUSDP/E Infinity

Eagle Pharmaceuticals, Inc.

$3.29MUSDP/E 1.6

Enorama Pharma AB (publ)

Gabather AB (publ)

Shuttle Pharmaceuticals Holdings, Inc.

$2.08MUSDP/E 35.5

CanadaBis Capital Inc.

Genix Pharmaceuticals Corporation

Petros Pharmaceuticals, Inc.

$173.7KUSDP/E 0.0

Clever Leaves Holdings Inc.

Indicators:|

Key Statistics

Company

Market Cap206.95M $

Enterprise Value297.73M $

Revenue (TTM)64.43M $

Gross Profit47.88M $

Net Income (TTM)-20.10M $

Revenue/Share1.213 USD

Last Price21.00 PLN

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees564

CountryPL

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINPLCLNPH00015

Valuation

P/E (Trailing)10.29

P/E (Forward)13.13

PEG—

EV/EBITDA61.37

EV/Revenue4.62

P/S3.21

P/B2.14

EPS (TTM)2.04

EPS (Forward)1.60

52W Range

18.5040% of range24.75

52W High24.75 PLN

52W Low18.50 PLN

Profitability

Gross Margin74.32%

Oper. Margin-9.75%

EBITDA Margin7.53%

Profit Margin42.58%

ROE-21.85%

ROA-17.35%

Growth

Revenue Growth24.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF6.04M $

CapEx (TTM)—

FCF Margin-9.82%

FCF Yield-3.06%

Net Debt11.29M $

Net Debt/EBITDA2.33

Balance Sheet

Debt/Equity10.15

Current Ratio1.20

Quick Ratio0.87

Book Value/Sh9.818 PLN

Cash/Share0.1690 PLN

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 PLN

Div. Yield—

5Y Avg Yield0.68%

Payout Ratio0.00%

Ex-Div DateJun 27, 2024

Pay Date—

Analyst Consensus

Rating—

Target (Mean)20.44 PLN

Upside (mean)-2.7%

Target Range16.00 PLN – 25.50 PLN

PLN16.00-2.7% to meanPLN25.50

# Analysts5

Ownership

Shares Out.38.91M

Float23.82M

Insiders55.70%

Institutions17.83%

Technical

SMA 5020.45 (+2.7%)

SMA 20021.15 (-0.7%)

Beta0.67

S&P 52W Chg20.25%

Avg Vol (30d)9.37K

Avg Vol (10d)5.27K

Technical Indicators

RSI (14)66.2

MACD-0.1503

MACD Signal-0.2543

MACD Hist.+0.1040

BB Upper20.53 PLN

BB Middle19.84 PLN

BB Lower19.15 PLN

BB Width6.96%

ATR (14)0.4788 PLN

Vol Ratio (20d)5.38x